Meorient (300795) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Meorient stock ¥11.88, price ¥10.98, upside +8.2%, quality 68 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
60‑month range ¥4.92 – ¥22.32 · fair‑value band ¥7.78 – ¥17.70 · the ¥10.98 price screens below the ¥11.88 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 9, 2026.
Follow Meorient in your weekly email
Every Wednesday you see whether Meorient is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Zhejiang Meorient Commerce Exhibition Inc. provides convention and exhibition services.
Show moreShow less
Its exhibitions include global series of professional exhibitions and global exhibitions; and AI smart exhibition, AI-guided digital communication at the exhibition, traditional exhibition, as well as Meo GPT, a digital marketing service through AI technology.
The company provides consulting services covers various dimensions, such as trade, investment and financing, local think tanks, and inward investment to Chinese companies and local governments.
In addition, it offers foreign market research and project feasibility analysis report; foreign legal, tax, and business negotiations; foreign project landing and business management; foreign policy guidance and public relations handling; collaborative relationship coordination and rights protection; business team building and international business training; and investment and financing services for foreign projects.
Further, the company focuses on organizing large-scale brand showcase trade fairs, high-end forums, conferences, seminars, and other customized events. The company was incorporated in 2010 and is headquartered in Shanghai, China.
Stock analysis
Meorient (300795) currently trades at ¥10.98, while our model-based Fair Value estimate is ¥11.88, so the stock looks roughly fairly valued today (gap 7.6%).
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ¥11.07 per share, and 5 of the 26 models we run sit above the ¥10.98 price.
Bear case: the Asset-Based group reads lowest at ¥1.67, and 21 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ¥7.78 (bear) to ¥17.70 (bull), the price of ¥10.98 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 68/100 (solid quality), in the Industrials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Meorient reported revenue of 784M CNY in FY2025 versus 182M CNY in FY2021, a compound +44.2%/yr. Reported net income was 137M CNY in FY2025.
Key figures
Market cap 3.2B CNY (≈ $486M) Small · P/E ratio 33.3 · P/S ratio 4.62 · EPS (TTM) ¥0.3300 · Dividend yield 1.8% · Net margin 14.0% · Return on equity 16.6% · Return on assets (EBIT) 13.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 65 out of 100 (low confidence).
What moves the price
The share trades about 39% below its 52-week high and 37% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −12% fair-value upside, at 8%, 300795 screens cheaper than that median.
Fair Value models
Bear¥7.78Fair Value ¥11.88Bull¥17.70
Price ¥10.98 · Upside +8.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.1115 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+4.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+31.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+52.7%
Start year 2020 (pandemic). Over 10 years: +11.0% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.8%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+12.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+10.3%
Dividend (yield on the price)1.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.10.3% vs −2.4%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−87% → 20%
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Revenue per share shrinking 8.5%/yr over ~10Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+15.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain.
After inflation (China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about +13.1% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Business Services · 230 stocks
Beats the industry median on 5/13 measures
Overall it trails its industry peers.
Valuation
Quality Score68 · Top 25%
Fair Value upside+8.2% · Below median
Profitability
Return on equity (12 months)16.6% · Above median
Return on assets15.5% · Top 25%
Net margin (12 months)14.0% · Top 25%
Operating margin (12 months)12.9% · Above median
Growth and dividend
Revenue growth (quarter YoY)−6.8% · Bottom 25%
Dividend yield (12 months)1.8% · Below median
Valuation Multiplesvs Specialty Business Services median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Meorient Fair Value". https://www.fairvalue-calculator.com/stock/300795
Frequently asked questions
Is Meorient (300795) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of ¥11.88 versus a price of ¥10.98, about +8% upside (fairly valued).
What is the fair value of 300795?
Our model-based fair value for Meorient is ¥11.88 (as of Nov 9, 2026), built from audited fundamentals. The current price: ¥10.98.
What is the quality score of 300795?
Meorient has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Meorient (300795)?
Our model-based price target is the fair value of ¥11.88 (as of Nov 9, 2026) from 26 valuation models. Cautious scenario ¥7.78, optimistic scenario ¥17.70. It is a calculation from audited fundamentals, not an analyst target.
What is the Meorient stock forecast for 2026?
Our models put fair value at ¥11.88, about +8% upside versus a price of ¥10.98 (fairly valued). Cautious scenario ¥7.78, optimistic scenario ¥17.70. The calculation is refreshed regularly with new filings.
What is the revenue of Meorient (300795)?
Meorient reported trailing-twelve-month revenue of about 703M CNY (latest available figure, as of Nov 9, 2026).
Does Meorient pay a dividend?
Meorient currently shows a dividend yield of 1.82% relative to its recent price (as of Nov 9, 2026).
How much is the dividend of Meorient (300795) and when is the ex-dividend date?
Meorient pays a dividend of ¥0.2 per share a year, a dividend yield of 1.8%. The last ex-dividend date was Apr 30, 2026. The payout ratio is 60.6% of earnings. Free cash flow covers the dividend 1.89 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into Meorient (300795)?
For today's price to be fair in a discounted-cash-flow model, Meorient would have to grow free cash flow by +15.0 % per year for five years (discount rate 10.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +52.7 % per year. Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain. As of Nov 9, 2026.
What discount rate (WACC) does the fair value of 300795 use?
Our models discount Meorient at 10.8 %: a base by market capitalisation (small), damped by beta 0.62, country premium for China. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Meorient that is +15.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.8 %) and the same formula as our fair value.
How much growth has Meorient (300795) delivered so far?
Over the past 5 years revenue at Meorient grew +52.7 % a year. The price currently implies free-cash-flow growth of +15.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Meorient (300795) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into Meorient (+15.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Meorient (300795)?
The free-cash-flow yield on the price is 3.47 % in the last fiscal year (free cash flow was negative over the last twelve months): that much free cash flow Meorient produces per unit of market value. When it exceeds the discount rate of our models (10.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Meorient (300795)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Meorient it is ¥11.88 per share (as of Nov 9, 2026), against a price of ¥10.98. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Meorient stock overvalued or undervalued in 2026?
As of Nov 9, 2026, 300795 trades below its calculated fair value: price ¥10.98, fair value ¥11.88, a gap of about +8% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 300795?
No. The price is what the market pays today (¥10.98); the fair value is what the company's own numbers justify (¥11.88). For Meorient the two are ¥0.9000 per share apart. That gap is exactly why we show both numbers side by side.
How much is Meorient worth?
The market values Meorient at about 3.2B CNY (market capitalisation, as of Nov 9, 2026). Per share that is ¥10.98; our models calculate a fair value of ¥11.88 per share.
What do the bullish and bearish scenarios say about 300795?
Our models span a range for Meorient: cautious scenario ¥7.78, base ¥11.88, optimistic ¥17.70 per share (as of Nov 9, 2026, price ¥10.98). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 300795?
Meorient trades at a price-to-earnings ratio of 33.3 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥11.88 is built from several models across several years. Other multiples: P/B 5.0, P/S 4.6, EV/EBITDA 21.1.
How solid is the balance sheet of Meorient (300795)?
Balance-sheet figures for Meorient (as of Nov 9, 2026): return on equity 16.6%. They feed the Quality Score of 68/100, which measures business quality independently of the share price.
How far is 300795 from its 52-week high?
Meorient trades at ¥10.98, about 39% below its 52-week high of ¥18.13 and 37% above the low of ¥8.03 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of ¥11.88 is for.
Which stocks are comparable to Meorient?
From the same area (Industrials) we also value Cintas Corporation, Thomson Reuters Corporation, Copart, Inc, Global Payments Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Meorient stock attractive at the current price?
The data as of Nov 9, 2026: price ¥10.98, calculated fair value ¥11.88 (+8%), Quality Score 68/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 300795 calculated?
We run Meorient through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥11.88 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Meorient currently trades 8% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Meorient (300795)?
The closing price on Nov 9, 2026 was ¥10.98. Our model-based fair value is ¥11.88, about +8% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Meorient right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (¥7.78 to ¥17.70) leaves room in how you read the outcome.
Where does the earnings growth of Meorient (300795) come from?
Earnings per share at Meorient grew −0.7 % a year from 2014 to 2025. Broken into its drivers: revenue per share −7.5 %, EBIT margin +6.2 %, tax rate +1.5 %, residual (interest, one-offs) −0.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Meorient
How large is the market capitalisation of Meorient (300795)?
The market capitalisation of Meorient is 3.2B CNY (≈ $486M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Meorient (300795)?
The price-to-sales ratio of Meorient is 4.62 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Meorient (300795)?
Earnings per share at Meorient are ¥0.3300 (price ÷ EPS = P/E 33.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Meorient (300795)?
The dividend yield of Meorient is 1.8% (payout 60.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Meorient (300795)?
The net margin of Meorient is 14.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Meorient (300795)?
The return on equity (ROE) of Meorient is 16.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Meorient (300795)?
On an EBIT basis the return on assets of Meorient is 13.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Meorient (300795)?
The operating margin of Meorient is 12.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Meorient (300795)?
Revenue at Meorient is growing −6.8% versus a year earlier (3y avg +31.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Meorient (300795)?
Earnings per share at Meorient are growing −69.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Meorient (300795) hold?
Meorient holds more cash than debt, 451M CNY net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Meorient in the live analysis
One click puts Meorient on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 9, 2026